Table 3.
Survival (%) | Chi-square | P value | HR (95% CI) | P value | |
---|---|---|---|---|---|
Age (years) | 0.686 | 0.408 | |||
≤60 | 16.7 | ||||
>60 | 21.1 | ||||
Gender | 1.841 | 0.175 | |||
Female | 38.5 | ||||
Male | 10.0 | ||||
Tumor length (cm) | 6.846 | 0.009 | 0.627 | ||
≤3 | 33.3 | 1.000 | |||
>3 | 8.0 | 1.229 (0.535–2.821) | |||
Tumor location | 0.024 | 0.877 | |||
Upper/middle | 20.0 | ||||
Lower | 16.7 | ||||
Vessel involvement | 1.068 | 0.301 | |||
Negative | 21.2 | ||||
Positive | 10.0 | ||||
Depth of invasion | 7.433 | 0.006 | 0.103 | ||
T1-2 | 33.3 | 1.000 | |||
T3-4a | 8.0 | 2.032 (0.867–4.766) | |||
Nodal metastasis | 9.687 | 0.002 | 0.092 | ||
Negative | 40.0 | 1.000 | |||
Positive | 7.1 | 2.182 (0.880–5.411) | |||
Chemoradiotherapy | 5.577 | 0.018 | 0.011 | ||
No | 5.9 | 1.000 | |||
Yes | 26.9 | 0.380 (0.180–0.803) | |||
NLR | 1.967 | 0.161 | |||
<3.5 | 22.2 | ||||
≥3.5 | 12.5 | ||||
PLR | 7.374 | 0.007 | 0.041 | ||
<150 | 25.0 | 1.000 | |||
≥150 | 6.7 | 2.272 (1.035–4.984) |